Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2022
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer, Andreas Rimner, Wei-Chu Victoria Lai, Raffaele Califano, et al.
Implications of RAS Mutational Status in Subsets of Patients With Newly Diagnosed Acute Myeloid Leukemia Across Therapy Subtypes, Daniel Rivera, Kunhwa Kim, Rashmi Kanagal-Shamanna, et al.
International Delphi Consensus Guidelines for Follow-Up After Prophylactic Total Gastrectomy: The Life After Prophylactic Total Gastrectomy (LAG-TG) Study, Geoffrey Roberts, Patrick R Benusiglio, Tanya Bisseling, et al.
International Delphi Consensus Guidelines for Follow-Up After Prophylactic Total Gastrectomy: The Life After Prophylactic Total Gastrectomy (LAP-TG) Study, Geoffrey Roberts, Patrick R Benusiglio, Tanya Bisseling, et al.
International Delphi Consensus Guidelines for Follow-Up After Prophylactic Total Gastrectomy: The Life After Prophylactic Total Gastrectomy (LAP-TG) Study, Geoffrey Roberts, Patrick R Benusiglio, Tanya Bisseling, et al.
Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn's Disease, Prema Robinson, Emily Magness, Kelsey Montoya, et al.
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC, Pedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Cristina P Rodriguez, Hyunseok Kang, Jessica L Geiger, et al.
Promoting Cancer Health Equity: A Qualitative Study of Mentee and Mentor Perspectives of a Training Program for Underrepresented Scholars in Cancer Health Disparities, Anastasia Rogova, Isabel Martinez Leal, Maggie Britton, et al.
Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors, Frank Rojas, Edwin Roger Parra, Ignacio Ivan Wistuba, et al.
Multidimensional Single-Cell Analysis Identifies a Role for CD2-CD58 Interactions in Clinical Antitumor T Cell Responses, Gabrielle Romain, Paolo Strati, Ali Rezvan, et al.
Gene-Gene Interaction of AhRwith and Within the Wntcascade Affects Susceptibility to Lung Cancer, Albert Rosenberger, Nils Muttray, Rayjean J Hung, et al.
Iam hiQ-A Novel Pair of Accuracy Indices for Imputed Genotypes, Albert Rosenberger, Viola Tozzi, Heike Bickeböller, et al.
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells, Uri Rozovski, Ivo Veletic, David M Harris, et al.
Prognostic Molecular Biomarkers in Chordomas: A Systematic Review and Identification of Clinically Usable Biomarker Panels, Franco Rubino, Christopher Alvarez-Breckenridge, Kadir Akdemir, et al.
Antibody Therapeutics for Epithelial Ovarian Cancer, Mason Ruiz, Ningyan Zhang, Anil K Sood, et al.
Immune Dysfunction Signatures Predict Outcomes and Define Checkpoint Blockade-Unresponsive Microenvironments in Acute Myeloid Leukemia, Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Re-Thinking Therapeutic Development for CNS Metastatic Disease, Chantal Saberian and Michael A Davies
Bone Marrow Endothelial Cells Increase Prostate Cancer Cell Apoptosis in 3D Triculture Model of Reactive Stroma, Lindsey K Sablatura, Tristen V Tellman, Aemin Kim, et al.
Genetic Variants Associated With Circulating Liver Injury Markers in Mexican Americans, a Population at Risk for Non-alcoholic Fatty Liver Disease, Caroline M Sabotta, Suet-Ying Kwan, Lauren E Petty, et al.
Selective IgA Deficiency in Spontaneously Hypertensive Rats With Gut Dysbiosis, Piu Saha, Blair Mell, Rachel M Golonka, et al.
CAR Treg Cells: Prime Suspects in Therapeutic Resistance, Neeraj Saini and Sattva S Neelapu
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma, Neeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Targeting TMEM205 Mediated Drug Resistance in Ovarian Clear Cell Carcinoma Using Oncolytic Virus, Uksha Saini, Brentley Q Smith, Kalpana Deepa Priya Dorayappan, et al.
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis, Rima M Saliba, Amin M Alousi, Joseph Pidala, et al.